Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 42 results for "glenn saldanha"

Out-licensing yes, but with a more ‘mature’ approach, says...

Glenn Saldanha does not believe that Glenmark has fallen silent on the licensing front. The next 12 to 18 months will see the company venture into out-licensing pacts with global partners to develop prospective drugs from the Glenmark stable, says Saldanha, ... Business Line, 4 days ago

2 images for "glenn saldanha"

Business Standard India, 4 months ago
Business Standard India, 7 months ago

Must Read: Full list of Forbes 100 Richest Indians

Mukesh Ambani : $22.7 billion Dilip Shanghvi : $16.9 billion Hinduja Brothers : $15.2billion Azim Premji : $15billion Pallonji Mistry : $13.9billion Lakshmi mittal : $12.5billion Godrej Family : $12.4billion Shiv Nadar : ...
 ZeeNews.com1 day ago Hurun India Rich List 2016  Hurun Report2 weeks ago

Cold response from Venezuela to India's plan of oil for drugs

The Indian government has been trying to push the oil-for-drugs barter plan for months now, similar to the one it worked out with Iran Hyderabad: India's oil-for-drugs barter plan with cash-strapped Venezuela to help recover millions of dollars in ...
 Livemint.com2 days ago

Glenmark announces the Discovery and Initiation of IND-enabling studies of a novel Bispecific Monoclonal Antibody targeting EGFR

Posted On: 2016-09-19 20:20:03 Glenmark Pharmaceuticals S.A. (GPSA), a wholly owned subsidiary of Glenmark Pharmaceuticals Limited India (GPL), has announced the discovery and initiation of IND-enabling studies for a novel clinical development ...
 Equity Bulls4 days ago Glenmark announces discovery and initiation of clinical development of novel anti-cancer drug  Livemint.com2 weeks ago Glenmark initiates IND-enabling studies targeting cancer  Moneycontrol.com2 weeks ago Glenmark begins IND enabling studies of bispecific monoclonal antibody, GBR 1372  PharmaBiz2 weeks ago

Raymond Pinto (85) Nyarma-Shirva

from Wilson Shirva Raymond Pinto( 85) son of the late Piad Pinto and the late Angeline Pinto, husband of Cecillia pinto and father of Gilbert/ Agnes, Benedicta / Charles, Robert / Veena, Rony Nobert / Preethi, Albert/ Shobha, passed away on 30 ...
 Daijiworldcom3 weeks ago
Business Standard India

Drug firms expect rebound in domestic biz

Drug companies are expecting an uptick in domestic sales, following a muted quarter which saw business slow down due to price caps and government ban on fixed dose combination drugs. Domestic sales grew 6.4 per cent in April-June quarter in ...
 Business Standard India1 month ago Drug companies expect rebound in domestic business  Business Standard India1 month ago

Indian drug makers feel pinch of price curbs as Q1 growth slows

India's pharmaceutical sector grew at 6.4% in the April-June quarter, down from 14.8% last year, largely due to the aggressive price controls by the government Indian drug makers are now feeling the pinch of the drug price controls put in place by ...
 Livemint.com1 month ago

New products, regulatory approvals to drive growth for Glenmark

- By The company is expecting strong growth in the current fiscal both from India and US. Major approvals are expected to drive growth for Glenmark, says Chairman and Managing Director
 Moneycontrol.com1 month ago
Financial Express

Glenmark's announces 23.96% net profit at Rs 2267.80 million for Q1 FY 2016-17

Consolidated revenue was at Rs 19,430.52 million, recording an increase of 17.92 per cent Glenmark Pharmaceuticals, the research-led global integrated pharma company announced its results for the first quarter ended June 30, 2016. For the ...
 Express Pharma1 month ago Glenmark Q1 profit rises 24% to Rs.226.8 crore  Livemint.com1 month ago Glenmark net up 24% at Rs 227 cr  Hindu Business Line1 month ago Glenmark Pharmaceuticals net profit up 23.96% in Q1  Yahoo! India1 month ago
Money Control

Glenmark Q1 profit up 24%, US biz grows 24% but margin shrinks

"The US business continues to perform well and the recent approvals for the business will ensure the growth momentum will continue. Europe business performed well due to strong growth witnessed by the UK subsidiary," Glenn Saldanha, chairman MD said.
 Money Control1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less